This Week in Science

In Science Translational Medicine this week, a Harvard University-led team reports a new test for pancreatic ductal adenocarcinoma (PDAC) that performs better than currently available diagnostics. The researchers used a multiplexed plasmonic assay to analyze circulating tumor-derived extracellular vesicles and identify a signature of five protein biomarkers that could be used to diagnose the disease with 86 percent sensitivity and 81 percent specificity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.